AURKB and cancer: Next, we evaluated the ability of Dato-DXd and CTL ADC to induce bystander antitumor effect when TROP2 3+ USC cells (ARK2) were admixed with negligible TROP2 expression cancer cells (ARK4) for an incubation period of 48 hours.